Open-Label Placebo Effects in Reducing Depression Severity Among Adults with Major Depressive Disorder: A Systematic Review and Meta-Analysis of Early Evidence

Background: Open-label placebo (OLP) represents an intervention where patients knowingly receive inert treatments associated with clinical benefits. This approach has demonstrated efficacy across multiple medical conditions. Meanwhile, major depressive disorder (MDD) affects 280 million people world...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Janet Mercedes Arévalo-Ipanaqué, Maria Letícia Gobo Silva, Ricardo Romero-Vucovich, Gianluca Conte, Matheus Gerhard Rosenfeld, Sergio José Fausto Girón, Lisa Gonzalez, Jordy Batista, Sofia Ines Volpi, Maximiliano Espinosa, Daniela Lorena Alvarado Rodriguez, Salvatore Minnella, Tadeus Lopez Ulloa, Nadine Aranis Seguic, Yazmin Heredia Allegretti, Johan Antonio De La Rosa Laureano, Cristian Camilo Bermudez, Letícia Watanabe Koyama, Maria Eduarda Nabhan de Souza, Somaya Althobaiti, Karen Gamonal, Folasade Mary Adeyemi, Luis Pedro Lorenzana, Aderibigbe Adeniyi Sheriff, Peter Benedek, Emilio Vilorio-Alvarez, Wajih Jawhar
Formato: Artículo
Publicado: 2026
Materias:
Acceso en línea:Enlace permanente (DOI o Handle)
Enlace permanente (DOI o Handle)
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!